Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations. 1998

J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
UMR 147 CNRS-Institut Curie, Section de Recherche, Paris, France.

A correlation analysis was performed on 223 breast carcinomas to assess the relationships between gene amplification, karyotypic and clinicopathological features. Homogeneously staining region (HSR) is the most frequent form of amplification found in breast cancer. HSR-containing tumours accounted for 60% of the cases. Although up to 40% of tumours with slightly altered karyotype contained HSRs, an excess of HSRs was found within the tumours whose karyotype showed the highest rates of rearranged chromosomes. HSRs were also found to be particularly frequent in small tumours of high histological grade and with a low expression of progesterone receptors. An excess of HSRs seems to be observed in younger patients, however, significant correlation could be demonstrated only for patients below 55 years and below 60 years, compared with older ones. With a 120-month follow-up for 152 patients, a significant association between the presence of HSRs and a shortened overall survival was observed. Altogether, the presence of HSRs appears to be a good indicator of poor prognosis. Further studies are needed to determine whether amplification of specific genes or cell ability to amplify is the most important parameter for tumour progression.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
May 1990, Genes, chromosomes & cancer,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
May 1992, Human pathology,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
June 1983, International journal of cancer,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
January 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
April 2013, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
March 1979, International journal of cancer,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
July 1994, Genes, chromosomes & cancer,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
May 1982, Cancer research,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
January 1984, Cancer genetics and cytogenetics,
J Bernardino, and M Gerbault-Seureau, and B Zafrani, and Y Dericke, and E Boudou, and H Magdelenat, and B Dutrillaux
March 1996, Cancer genetics and cytogenetics,
Copied contents to your clipboard!